# Adaptive Radiotherapy for Safe Hypofractionation

> **NCT07516210** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 264 (estimated)

## Conditions studied

- Cancer
- Endometrial Cancer
- Prostate Cancer
- Cervical Cancer
- Rectal Cancers

## Interventions

- **RADIATION:** Adaptive Hypofractionated Radiotherapy
- **RADIATION:** Standard-of-care Radiotherapy

## Key facts

- **NCT ID:** NCT07516210
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2030-05
- **Final completion:** 2030-05
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516210, "Adaptive Radiotherapy for Safe Hypofractionation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07516210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*